These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36482903)

  • 1. Novel insight of N
    Wang K; Kan Q; Ye Y; Qiu J; Huang L; Wu R; Yao C
    Front Genet; 2022; 13():1055396. PubMed ID: 36482903
    [No Abstract]   [Full Text] [Related]  

  • 2. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment.
    Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X
    Front Immunol; 2022; 13():888650. PubMed ID: 35572541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
    Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
    [No Abstract]   [Full Text] [Related]  

  • 4. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment.
    Liu F; Yu X; He G
    J Oncol; 2021; 2021():9987376. PubMed ID: 34745261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
    Quan Y; Zhang X; Ping H
    Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm.
    Fu C; Feng L; Zhang J; Sun D
    Ann Transl Med; 2022 May; 10(10):547. PubMed ID: 35722410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic m6A modification patterns and score system in melanoma patients.
    Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y
    Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma.
    Xu H; Yin L; Xu Q; Xiang J; Xu R
    Cancer Cell Int; 2022 May; 22(1):199. PubMed ID: 35606813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm.
    Li T; Wang T; Jing J; Sun L
    J Inflamm Res; 2021; 14():4245-4258. PubMed ID: 34511965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes based on N6-methyladenosine RNA methylation demonstrate the heterogeneity of immune and biological functions in pediatric septic shock.
    Wang H; Huang J; Guo C; Wu J; Zhang L; Ren X; Gan L
    Heliyon; 2023 Oct; 9(10):e20714. PubMed ID: 37842565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
    Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
    Front Genet; 2021; 12():752025. PubMed ID: 35046996
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
    Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
    Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
    Zhou S; Hua R; Quan S
    J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
    Luo Y; Sun X; Xiong J
    Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
    [No Abstract]   [Full Text] [Related]  

  • 17. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics.
    Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L
    Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study.
    Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L
    Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
    Gu J; Bi F
    Front Genet; 2021; 12():671179. PubMed ID: 34306015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer.
    Sheng G; Wang T; Gao Y; Wu H; Wu J
    Sci Rep; 2023 Nov; 13(1):19670. PubMed ID: 37952076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.